BALCX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.37B
FBALX
Price
$31.08
Change
+$0.02 (+0.06%)
Updated
Jul 18 closing price
Net Assets
57.46B
Interact to see
Advertisement

BALCX vs FBALX

Header iconBALCX vs FBALX Comparison
Open Charts BALCX vs FBALXBanner chart's image
American Funds American Balanced C
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.37B
Fidelity Balanced
Price$31.08
Change+$0.02 (+0.06%)
VolumeN/A
Net Assets57.46B
BALCX vs FBALX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. FBALX commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and FBALX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 252B vs. FBALX (57.5B). FBALX pays higher dividends than BALCX: FBALX (1.69) vs BALCX (1.19). BALCX was incepted earlier than FBALX: BALCX (24 years) vs FBALX (39 years). BALCX (1.31) is less costly to investors than FBALX (0.47). BALCX is a more actively managed with annual turnover of: 44.00 vs. FBALX (24.00). FBALX has a lower initial minimum investment than BALCX: FBALX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 6.23 vs. FBALX (5.88). BALCX return over 5 years is better than : 34.75 vs. FBALX (29.84).
BALCXFBALXBALCX / FBALX
Total Expense Ratio1.310.47279%
Annual Report Gross Expense Ratio1.310.47279%
Fund Existence24 years39 years-
Gain YTD7.7146.051127%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets252B57.5B438%
Annual Yield % from dividends1.191.6971%
Returns for 1 year6.235.88106%
Returns for 3 years33.4830.97108%
Returns for 5 years34.7529.84116%
Returns for 10 years55.4747.89116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTM1.400.07
+5.26%
Castellum
REPX26.551.30
+5.15%
Riley Exploration Permian
WLK83.432.18
+2.68%
Westlake Corp
FHI47.060.57
+1.23%
Federated Hermes
LYRA8.53N/A
N/A
Lyra Therapeutics Inc